Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL820267 | 0.96 | MEN1 (0.31) | MEN1KMT2ATDP1 | |
| SCHEMBL3847172 | 0.92 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL3843949 | 0.77 | MEN1 (0.31) | MEN1KMT2ATDP1 | |
| SCHEMBL708310 | 0.76 | MEN1 (0.50) | MEN1KMT2ATDP1 | |
| SCHEMBL1888715 | 0.75 | MEN1 (0.33) | MEN1KMT2ATDP1 | |
| SCHEMBL4332236 | 0.73 | — | — | |
| Methacrylic Acid SCHEMBL3847173 | 0.72 | — | — | |
| SCHEMBL31049981 | 0.71 | MEN1 (0.60) | MEN1KMT2ATDP1 | |
| SCHEMBL1883029 | 0.69 | — | — | |
| SCHEMBL3843953 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1460057-B1 | PERFLUOROADAMANTYL ACRYLATE COMPOUND AND INTERMEDIATE THEREFOR | IDEMITSU KOSAN CO (JP) | 2006-12-13 | — | — | EP | claimed |
| US-7084295-B2 | Perfluoroadamantyl acrylate compound and intermediate therefor | IDEMITSU KOSAN CO., LTD. (JP) | 2006-08-01 | — | — | US | claimed |
| US-20050131247-A1 | Perfluoroadamantly acrylate compound and intermediate therefor | IDEMITDU PETROCHEMICAL CO., LTD (JP) | 2005-06-16 | — | — | US | claimed |
| EP-1460057-A1 | PERFLUOROADAMANTYL ACRYLATE COMPOUND AND INTERMEDIATE THEREFOR | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2004-09-22 | — | — | EP | claimed |
| EP-1730593-B1 | A PROCESS OF IMAGING A DEEP ULTRAVIOLET PHOTORESIST WITH A TOP COATING | MERCK PATENT GMBH (DE) | 2019-04-24 | — | — | EP | disclosed |
| US-8802632-B2 | Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof | MEDAREX, L.L.C. (US) | 2014-08-12 | — | — | US | disclosed |
| US-8535862-B2 | Electrophotographic photoreceptor, image forming apparatus, and process cartridge | RICOH COMPANY, LTD. (JP) | 2013-09-17 | — | — | US | disclosed |
| CN-101243028-B | Fluorine-containing adamantane derivative, fluorine-containing adamantane derivative having polymerizable group, and resin composition containing same | IDEMITSU KOSAN CO | 2012-03-28 | — | — | CN | disclosed |
| US-20120008978-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, IMAGE FORMING APPARATUS, AND PROCESS CARTRIDGE | RICOH COMPANY, LTD. (JP) | 2012-01-12 | — | — | US | disclosed |
| US-7939682-B2 | Fluorine-containing adamantane derivative, fluorine-containing adamantane derivative having polymerizable group, and resin composition containing same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-05-10 | — | — | US | disclosed |
| US-20090149665-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, AND RESIN COMPOSITION CONTAINING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-06-11 | — | — | US | disclosed |
| US-20090148706-A1 | OPTICAL WAVEGUIDE HAVING PERFLUOROADAMANTANE STRUCTURE | OMRON CORPORATION (JP) | 2009-06-11 | — | — | US | disclosed |
| US-20050202340-A1 | Process of imaging a deep ultraviolet photoresist with a top coating and materials thereof | MERCK PATENT GMBH (DE) | 2005-09-15 | — | — | US | disclosed |
| US-20050131247-A1 | Perfluoroadamantly acrylate compound and intermediate therefor | IDEMITDU PETROCHEMICAL CO., LTD (JP) | 2005-06-16 | — | — | US | disclosed |
| US-20050130056-A1 | Polymer compound, resist composition and dissolution inhibitor agent containing the polymer compound | UBS AG, STAMFORD BRANCH | 2005-06-16 | — | — | US | disclosed |
| EP-1516867-A1 | HALOGENOACETOXYADAMANTANE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF | IDEMITSU KOSAN CO., LTD. (JP) | 2005-03-23 | — | — | EP | disclosed |
| US-20050004391-A1 | Adamantyl vinyl ether compound and production process for the same | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2005-01-06 | — | — | US | disclosed |
| EP-1486480-A1 | Adamantyl vinyl ether compound and production process for the same | Idemitsu Petrochemical Co., Ltd. (JP) | 2004-12-15 | — | — | EP | disclosed |
| EP-1460057-A1 | PERFLUOROADAMANTYL ACRYLATE COMPOUND AND INTERMEDIATE THEREFOR | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2004-09-22 | — | — | EP | disclosed |
| WO-2004050725-A1 | POLYMER COMPOUND, RESIST COMPOSITION AND DISSOLUTION INHIBITOR AGENT CONTAINING THE POLYMER COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2004-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131247-A1 | Perfluoroadamantly acrylate compound and intermediate therefor | FFAR3, PFAS, FFAR1 | MEN1 1992/4885KMT2A 1359/4885TDP1 2871/4885 |
| US-20050004391-A1 | Adamantyl vinyl ether compound and production process for the same | NOTUM, CYP4A11, CYP4F11 | MEN1 1442/4885KMT2A 3398/4885TDP1 3856/4885 |
| US-20090149665-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, AND RESIN COMPOSITION CONTAINING SAME | TAS1R1, ADORA1, TAS2R1 | MEN1 3355/4885KMT2A 3820/4885TDP1 768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.